EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Modern Perspectives on Diagnosing and Treating Dry Eye Disease in Elderly Patients

Aleksandra Gródek, Dominik Iskrzyński, Mikołaj Dubiel, Wiktoria Dubiel, Patryk Obajtek, Anna Sopel, Sylwia Sanakiewicz, Julia Iglantowicz, Aleksandra Bułat, Julia Jasińska

Quality in Sport · 08.07.2026 · 61 · 73018

DOI: 10.12775/qs.2026.61.73018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Quality in Sport, online erschienen am 08.07.2026. Verfasst von Aleksandra Gródek und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dry eye disease (DED) is a common multifactorial disorder of the ocular surface characterized by tear film instability, ocular discomfort, visual disturbance, and chronic inflammation. The aim of this review was to summarise current evidence regarding the pathophysiology, risk factors, diagnosis, and management of dry eye disease, with particular emphasis on its impact in the elderly population. Material and methods. A narrative literature review with PRISMA-informed methodology was conducted using PubMed, Web of Science, and Google Scholar. Literature published within the last 10 years concerning dry eye disease, ocular surface aging, meibomian gland dysfunction, and treatment strategies was analysed.

Results

Dry eye disease is strongly associated with age-related changes in the lacrimal glands, meibomian glands, ocular surface epithelium, and neural regulation of tear secretion. Additional contributing factors include systemic comorbidities, polypharmacy, hormonal alterations, and environmental exposures. The most common clinical manifestations include ocular irritation, dryness, burning, foreign body sensation, fluctuating vision, and reduced visual quality, all of which can significantly impair daily functioning and quality of life. Diagnosis is based on a combination of patient-reported symptoms and clinical assessment of tear film stability and ocular surface integrity. Management strategies include environmental modifications, artificial tear supplementation, anti-inflammatory therapy, autologous serum eye drops, punctal occlusion, scleral lenses, and surgical options in severe or refractory cases.

Conclusions

Dry eye disease in elderly patients is a progressive, multifactorial condition requiring early recognition and individualized, stepwise management to prevent disease progression and optimize quality of life.

Zitieren

APA

Gródek, A., Iskrzyński, D., Dubiel, M., Dubiel, W., Obajtek, P., Sopel, A., Sanakiewicz, S., Iglantowicz, J., Bułat, A., & Jasińska, J. (2026). Modern Perspectives on Diagnosing and Treating Dry Eye Disease in Elderly Patients. Quality in Sport, 61, 73018. https://doi.org/10.12775/qs.2026.61.73018

Vancouver

Gródek A, Iskrzyński D, Dubiel M, Dubiel W, Obajtek P, Sopel A, et al. Modern Perspectives on Diagnosing and Treating Dry Eye Disease in Elderly Patients. Quality in Sport. 2026;61:73018. doi:10.12775/qs.2026.61.73018

BibTeX
@article{Grdek2026,
  author = {Gródek, Aleksandra and Iskrzyński, Dominik and Dubiel, Mikołaj and Dubiel, Wiktoria and Obajtek, Patryk and Sopel, Anna and Sanakiewicz, Sylwia and Iglantowicz, Julia and Bułat, Aleksandra and Jasińska, Julia},
  title = {Modern Perspectives on Diagnosing and Treating Dry Eye Disease in Elderly Patients},
  journal = {Quality in Sport},
  year = {2026},
  volume = {61},
  pages = {73018},
  doi = {10.12775/qs.2026.61.73018}
}
Kostenlos starten →